Analysts Rate Core Scientific as “Moderate Buy” Amid Market Insights

Core Scientific, Inc. (NASDAQ:CORZ) has garnered an average recommendation of “Moderate Buy” from analysts monitoring the company, according to data from MarketBeat.com. This assessment comes from a total of twenty-two research firms, with two recommending a sell, six advising a hold, thirteen endorsing a buy, and one issuing a strong buy recommendation. The consensus among these analysts indicates an average 12-month price target of approximately $23.18 for the stock.

Several analysts have recently expressed their views on Core Scientific’s stock performance. Notably, Craig Hallum set a price target of $27.00 in a research note dated October 31. Similarly, Citizens JMP upgraded the stock from “market perform” to “outperform,” setting a target price of $30.00 in a report published on December 18. Jefferies Financial Group also set a target price of $24.00 and rated the stock as a “buy” on October 28. Other firms, including Roth Capital and Cantor Fitzgerald, have reiterated positive ratings while adjusting their price targets to $26.00 and $18.00, respectively.

In addition to analyst ratings, shifts in institutional holdings reflect growing interest in Core Scientific. For instance, Allworth Financial LP dramatically increased its stake by 206.5% during the third quarter, bringing its total to 1,410 shares, valued at approximately $25,000. Other institutions, such as HHM Wealth Advisors LLC and Osaic Holdings Inc., also expanded their positions, indicating a trend among investors to capitalize on the company’s potential growth.

Core Scientific’s Market Position and Stock Performance

Core Scientific opened trading at $15.29 on Wednesday, with its shares experiencing a 50-day simple moving average of $17.28 and a 200-day average of $15.81. The stock has shown volatility, with a one-year low of $6.20 and a high of $23.63. The company currently holds a market capitalization of $4.74 billion and a price-to-earnings ratio of 101.94, reflecting investor sentiment and market dynamics.

Core Scientific recently announced its quarterly earnings on October 24, reporting an earnings per share (EPS) of ($0.46), which surpassed the consensus estimate of ($0.85) by $0.39. The company recorded revenue of $81.10 million for the quarter, falling short of the anticipated $107.18 million. Analysts anticipate that Core Scientific will achieve an EPS of 0.52 for the current fiscal year, highlighting expectations for improved financial performance moving forward.

About Core Scientific

Core Scientific, Inc. operates as a significant player in the blockchain infrastructure and digital asset mining sector. The company specializes in developing, owning, and managing high-performance data centers tailored for the mining of Bitcoin and other proof-of-work cryptocurrencies. Beyond its mining operations, Core Scientific provides a suite of services, including colocation, hosting, and managed services, aimed at institutional clients and enterprise users. This encompasses hardware procurement, deployment, maintenance, real-time monitoring, power management, and network connectivity.

As the landscape of digital assets continues to evolve, Core Scientific’s strategic positioning and analyst endorsements suggest a potentially bright future, contingent on market conditions and company performance.